全文获取类型
收费全文 | 24522篇 |
免费 | 1820篇 |
国内免费 | 79篇 |
专业分类
耳鼻咽喉 | 267篇 |
儿科学 | 562篇 |
妇产科学 | 496篇 |
基础医学 | 3392篇 |
口腔科学 | 743篇 |
临床医学 | 2880篇 |
内科学 | 4905篇 |
皮肤病学 | 208篇 |
神经病学 | 2640篇 |
特种医学 | 952篇 |
外国民族医学 | 2篇 |
外科学 | 2977篇 |
综合类 | 340篇 |
一般理论 | 24篇 |
预防医学 | 1951篇 |
眼科学 | 486篇 |
药学 | 2021篇 |
中国医学 | 20篇 |
肿瘤学 | 1555篇 |
出版年
2023年 | 97篇 |
2022年 | 148篇 |
2021年 | 375篇 |
2020年 | 242篇 |
2019年 | 331篇 |
2018年 | 376篇 |
2017年 | 350篇 |
2016年 | 403篇 |
2015年 | 496篇 |
2014年 | 693篇 |
2013年 | 1046篇 |
2012年 | 1596篇 |
2011年 | 1727篇 |
2010年 | 1012篇 |
2009年 | 875篇 |
2008年 | 1657篇 |
2007年 | 1608篇 |
2006年 | 1604篇 |
2005年 | 1700篇 |
2004年 | 1556篇 |
2003年 | 1529篇 |
2002年 | 1437篇 |
2001年 | 300篇 |
2000年 | 229篇 |
1999年 | 315篇 |
1998年 | 375篇 |
1997年 | 285篇 |
1996年 | 270篇 |
1995年 | 256篇 |
1994年 | 209篇 |
1993年 | 184篇 |
1992年 | 177篇 |
1991年 | 160篇 |
1990年 | 144篇 |
1989年 | 154篇 |
1988年 | 149篇 |
1987年 | 134篇 |
1986年 | 141篇 |
1985年 | 147篇 |
1984年 | 162篇 |
1983年 | 158篇 |
1982年 | 199篇 |
1981年 | 165篇 |
1980年 | 185篇 |
1979年 | 99篇 |
1978年 | 119篇 |
1977年 | 110篇 |
1976年 | 84篇 |
1975年 | 89篇 |
1974年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Susan B Roberts Rachel E Silver Sai Krupa Das Roger A Fielding Cheryl H Gilhooly Paul F Jacques Jennifer M Kelly Joel B Mason Nicola M McKeown Meaghan A Reardon Sheldon Rowan Edward Saltzman Barbara Shukitt-Hale Caren E Smith Allen A Taylor Dayong Wu Fang Fang Zhang Karen Panetta Sarah Booth 《Advances in nutrition (Bethesda, Md.)》2021,12(4):1438
992.
993.
Roger Haber MD Joanna A. Chebl MD Maria El Gemayel MD Antoine Salloum MD 《International journal of dermatology》2020,59(12):1458-1465
Characterized chiefly by hypereosinophilia and angioedema, Gleich syndrome is a rare disorder with unclear clinical and therapeutic findings. Other symptoms include increased IgM levels, weight gain, fever, and urticaria. Herein we review Gleich syndrome and assess clinical features, epidemiology, and treatment options. Thirty-two articles including case reports or case series of eosinophilic angioedema and Gleich syndrome were included. Data regarding patient age, gender, and history, clinical and biological manifestations, and treatment protocols were recorded. The most common clinical findings include recurrent or non-recurrent angioedema, fever, urticaria, weight gain, blood eosinophilia, and elevated immunoglobulin levels. Corticosteroid therapy is the mainstay of treatment. Gleich syndrome is a distinctive hypereosinophilic entity with a benign course and good response to systemic corticosteroids. More studies are needed to evaluate the pathophysiology of this syndrome and lead to better therapeutic options. 相似文献
994.
Yoshio Okada PhD Sheraz Khan PhD Ashley Curran BS Banu Ahtam DPhil Matti S. Hämäläinen DSc Roger D. Traub MD Phillip L. Pearl MD 《Annals of neurology》2020,88(2):418-422
Neoplastic or dysplastic neuronal tissue in the brain stem and cerebellum can become epileptogenic in pediatric patients. However, it is unknown whether such tissue may transform intrinsic properties of the human cerebellum, making it capable of generating epileptic population activity. We noninvasively detected epileptiform signals unaveraged in a pediatric patient with epilepsy due to a tumor in the middle cerebellar peduncle. Analysis of generators of the signals revealed that the cerebellum ipsilateral and contralateral to the tumor was the dominant interictal spike generator and could initiate ictal activity, suggesting that human cerebellum may become capable of intrinsically generating epileptic activity. ANN NEUROL 2020;88:418–422. 相似文献
995.
Romina Vuono PhD Antonina Kouli MSc Emilie M. Legault BSc Lauriane Chagnon DEC Kieren S. Allinson FRCPath Alberto La Spada BSc REGISTRY Investigators of the European Huntington's Disease Network Ida Biunno PhD Roger A. Barker MRCP PhD Janelle Drouin-Ouellet PhD 《Movement disorders》2020,35(3):401-408
996.
Elise Roger Cedric Pichat Laurent Torlay Olivier David Felix Renard Sonja Banjac Arnaud Atty Lorella Minotti Laurent Lamalle Philippe Kahane Monica Baciu 《Human brain mapping》2020,41(3):779-796
Mesial temporal lobe epilepsy (mTLE) affects the brain networks at several levels and patients suffering from mTLE experience cognitive impairment for language and memory. Considering the importance of language and memory reorganization in this condition, the present study explores changes of the embedded language‐and‐memory network (LMN) in terms of functional connectivity (FC) at rest, as measured with functional MRI. We also evaluate the cognitive efficiency of the reorganization, that is, whether or not the reorganizations support or allow the maintenance of optimal cognitive functioning despite the seizure‐related damage. Data from 37 patients presenting unifocal mTLE were analyzed and compared to 48 healthy volunteers in terms of LMN‐FC using two methods: pairwise correlations (region of interest [ROI]‐to‐ROI) and graph theory. The cognitive efficiency of the LMN‐FC reorganization was measured using correlations between FC parameters and language and memory scores. Our findings revealed a large perturbation of the LMN hubs in patients. We observed a hyperconnectivity of limbic areas near the dysfunctional hippocampus and mainly a hypoconnectivity for several cortical regions remote from the dysfunctional hippocampus. The loss of FC was more important in left mTLE (L‐mTLE) than in right (R‐mTLE) patients. The LMN‐FC reorganization may not be always compensatory and not always useful for patients as it may be associated with lower cognitive performance. We discuss the different connectivity patterns obtained and conclude that interpretation of FC changes in relation to neuropsychological scores is important to determine cognitive efficiency, suggesting the concept of “connectome” would gain to be associated with a “cognitome” concept. 相似文献
997.
998.
Tuong L. Nguyen Shuai Li Gillian S. Dite Ye K. Aung Christopher F. Evans Ho N. Trinh Laura Baglietto Jennifer Stone Yun-Mi Song Joohon Sung Dallas R. English Mark A. Jenkins Pierre-Antoine Dugué Roger L. Milne Melissa C. Southey Graham G. Giles Malcolm C. Pike John L. Hopper 《International journal of cancer. Journal international du cancer》2020,147(2):375-382
Interval breast cancers (those diagnosed between recommended mammography screens) generally have poorer outcomes and are more common among women with dense breasts. We aimed to develop a risk model for interval breast cancer. We conducted a nested case–control study within the Melbourne Collaborative Cohort Study involving 168 interval breast cancer patients and 498 matched control subjects. We measured breast density using the CUMULUS software. We recorded first-degree family history by questionnaire, measured body mass index (BMI) and calculated age-adjusted breast tissue aging, a novel measure of exposure to estrogen and progesterone based on the Pike model. We fitted conditional logistic regression to estimate odds ratio (OR) or odds ratio per adjusted standard deviation (OPERA) and calculated the area under the receiver operating characteristic curve (AUC). The stronger risk associations were for unadjusted percent breast density (OPERA = 1.99; AUC = 0.66), more so after adjusting for age and BMI (OPERA = 2.26; AUC = 0.70), and for family history (OR = 2.70; AUC = 0.56). When the latter two factors and their multiplicative interactions with age-adjusted breast tissue aging (p = 0.01 and 0.02, respectively) were fitted, the AUC was 0.73 (95% CI 0.69–0.77), equivalent to a ninefold interquartile risk ratio. In summary, compared with using dense breasts alone, risk discrimination for interval breast cancers could be doubled by instead using breast density, BMI, family history and hormonal exposure. This would also give women with dense breasts, and their physicians, more information about the major consequence of having dense breasts—an increased risk of developing an interval breast cancer. 相似文献
999.
Elisa Funck-Brentano Bouchra Baghad Magali Fort Iman Aouidad Anissa Roger Alain Beauchet Yves Otmezguine Astrid Blom Christine Longvert Blandine Boru Philippe Saiag 《International journal of cancer. Journal international du cancer》2020,147(6):1707-1714
Advanced melanoma patients who failed anti-PD-1 therapy have limited options. We analyzed a cohort of 133 advanced melanoma patients receiving anti-PD-1 monotherapy in a referral center between April 2015 and December 2017, and included the 26 patients with confirmed progressive (PD) or stable disease who received additional radiotherapy with an unmodified anti-PD-1 mAb regimen. Tumor evaluations were done on radiated and nonradiated (RECIST 1.1) lesions, with abscopal effect defined as a partial (PR) or complete response (CR) outside radiated fields. Primary endpoint was the CR + PR rate in radiated + nonradiated lesions. Secondary endpoints were progression-free survival (PFS), melanoma-specific survival (MSS) and safety. First late radiotherapy, consisting of hypofractionated radiotherapy (3–5 sessions, 20–26 Gy), standard palliative radiotherapy or brain radiosurgery was begun after a median of 6.3 months of anti-PD-1 in 23, 2 and 1 patient(s), respectively. Best response was 8 (31%) CR, 2 (8%) profound PR allowing surgical resection of remaining metastases and 16 (62%) PD. Abscopal effect was seen in 35% of patients. Median PFS and MSS since anti-PD-1 initiation was 15.2 [95% CI: 8.0 not achieved (na)] and 35.3 [95% CI: 18.5 na] months, respectively. PFS curves seemed to achieve a plateau. We discontinued anti-PD-1 therapy in 9/10 of patients with no residual evaluable disease and observed one relapse after a median of 10 months off anti-PD1-therapy. No unusual adverse event was recorded. Limitations of the study include its retrospective nature and limited size. Hypofractionated radiotherapy may enhance anti-PD1 monotherapy efficacy in patients who previously failed anti-PD-1 therapy. Controlled studies are needed. 相似文献
1000.
S. Ghazaleh Dashti Julie A. Simpson Amalia Karahalios Vivian Viallon Margarita Moreno-Betancur Lyle C. Gurrin Robert J. MacInnis Brigid M. Lynch Laura Baglietto Howard A. Morris Marc J. Gunter Pietro Ferrari Roger L. Milne Graham G. Giles Dallas R. English 《International journal of cancer. Journal international du cancer》2020,146(6):1541-1552
Adiposity increases estrogen receptor (ER)-positive postmenopausal breast cancer risk. While mechanisms underlying this relationship are uncertain, dysregulated sex-steroid hormone production and insulin signaling are likely pathways. Our aim was to quantify mediating effects of fasting insulin and free estradiol in the adiposity and ER-positive postmenopausal breast cancer association. We used data from a case–cohort study of sex hormones and insulin signaling nested within the Melbourne Collaborative Cohort Study. Eligible women, at baseline, were not diagnosed with cancer, were postmenopausal, did not use hormone therapy and had no history of diabetes or diabetes medication use. Women with ER-negative disease or breast cancer diagnosis within the first follow-up year were excluded. We analyzed the study as a cumulative sampling case–control study with 149 cases and 1,029 controls. Missing values for insulin and free estradiol were multiply imputed with chained equations. Interventional direct (IDE) and indirect (IIE) effects were estimated using regression-based multiple-mediator approach. For women with body mass index (BMI) >30 kg/m2 compared to women with BMI 18.5–25 kg/m2, the risk ratio (RR) of breast cancer was 1.75 (95% confidence interval [CI] 1.05–2.91). The estimated IDE (RR) not through the mediators was 1.03 (95% CI 0.43–2.48). Percentage mediated effect through free estradiol was 72% (IIE-RR 1.56; 95% CI 1.11–2.19). There was no evidence for an indirect effect through insulin (IIE-RR 1.12; 95% CI 0.68–1.84; 28% mediated). Our results suggest that circulating free estradiol plays an important mediating role in the adiposity–breast cancer relationship but does not explain all of the association. 相似文献